Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant health challenge, particularly in developing countries. This article aims to highlight recent advancements and best practices in the management of this disease, providing a comprehensive guide for healthcare professionals.
Accurate and prompt diagnosis of enteric fever is crucial. Conventional culture methods, though gold standard, are time-consuming and lack sensitivity. Advances in molecular diagnostics, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), offer rapid, sensitive, and specific detection of the causative organisms. These techniques also aid in identifying antibiotic resistance, crucial for effective treatment planning.
Antimicrobial resistance is a pressing concern in enteric fever management. The emergence of extensively drug-resistant (XDR) strains necessitates the use of newer antimicrobials. Azithromycin has shown effectiveness against multi-drug resistant strains, while newer agents like ceftriaxone and carbapenems are used for XDR strains. Vaccination remains a crucial preventative measure, with the newer Typhoid Conjugate Vaccines (TCV) showing promising results in reducing disease incidence.
Best practices include early diagnosis, appropriate use of antimicrobials, and preventive strategies. Clinicians should consider enteric fever in febrile patients with relevant travel or contact history. Empirical therapy should be guided by local antimicrobial resistance patterns. Vaccination, particularly TCV, should be promoted in high-risk populations. Additionally, improving sanitation and safe water supply are essential public health measures.
Managing enteric fever involves a multi-faceted approach, incorporating advancements in diagnostic techniques and treatment modalities. Adherence to best practices, including appropriate antimicrobial use and preventive measures, is crucial. Healthcare professionals play a pivotal role in combating this disease, through timely diagnosis, effective treatment, and patient education on preventive measures.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation